Dive Brief:
- Medtronic will shutter its Santa Rosa, California, site in about two years, spokesperson Justin Paquette said Friday in an email to MedTech Dive. The decision follows a review of global operations.
- The planned closure of the site comes as the medtech giant combines its cardiac surgery and aortic businesses to create a new operating unit focused on cardiovascular surgery. The consolidation was recently announced in a LinkedIn post.
- Medtronic is also integrating its structural heart, coronary and renal denervation businesses to form an interventional cardiology therapies unit, Paquette said.
Dive Insight:
Medtronic has operated a location in Santa Rosa since acquiring stent manufacturer Arterial Vascular Engineering in 1998.
The company made the “difficult but strategic decision” to close the site after reviewing its global operations to ensure it is positioned for long-term growth and to meet the evolving needs of patients and healthcare providers, Paquette said.
Medtronic did not confirm the number of employees affected by the closure. The Press Democrat reported that 370 workers are affected…